Start Slowly: If you choose to supplement, consider starting with a lower dose and gradually increasing it to assess your tolerance
2008, "How meds i Page 26 and 27: Avisar D, Lester Y, and Ronen D
Phase 3 programs are in progress for small-molecule oral GLP-1R agonists
Consider your injection timing carefully
Several studies have investigated performance of GO in dye degradation with promising results 122,184,185
GLP-1 medications are often well suited for patients who: Experience frequent hunger or difficulty with portion control Respond well to appetite suppression alone Prefer a slower, more gradual weight loss trajectory Are sensitive to medications and benefit from a single-pathway approach While GLP-1 therapies can be highly effective, they may be less impactful for patients with significant insulin resistance or deeper metabolic dysfunction